| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/26/2000 | EP0994722A1 Method of removing endotoxin from vaccines |
| 04/26/2000 | EP0994721A1 Nerve growth factor as a vaccine adjuvant |
| 04/26/2000 | EP0994720A1 Use of bromelain in the manufacture of a medicament for enhancement of intestinal permeability |
| 04/26/2000 | EP0994719A1 Use of hyaluronidase in the manufacturing of a drug for the treatment of inflammation |
| 04/26/2000 | EP0994718A1 Gonadotropin releasing hormone antagonist |
| 04/26/2000 | EP0994717A1 Treatment of autoimmune disease using tolerization in combination with methotrexate |
| 04/26/2000 | EP0994707A1 Inhibitors of naaladase enzyme activity |
| 04/26/2000 | EP0994706A1 Method and compositions for administering taxanes orally to human patients |
| 04/26/2000 | EP0994700A1 Methods of removing residual solvent from nasal drug delivery compositions |
| 04/26/2000 | EP0994696A1 Controlled release pharmaceutical preparation with ace inhibitor as active agent |
| 04/26/2000 | EP0925305B1 Cyclitol containing carbohydrates from human tissue which regulate lipogenic activity |
| 04/26/2000 | EP0925304B1 Cyclitol containing carbohydrates from human tissue which regulate glycogen metabolism |
| 04/26/2000 | EP0873417A4 Compositions for the detection of proteases in biological samples and methods of use thereof |
| 04/26/2000 | EP0865291A4 Localized intravascular delivery of tfpi for inhibition of restenosis in recanalized blood vessels |
| 04/26/2000 | EP0832130B1 Separating polymerized from unpolymerized hemoglobin using hydroxyapatite |
| 04/26/2000 | EP0832127B1 Synthetic peptides and pharmaceutical compositions comprising them |
| 04/26/2000 | EP0830061B1 Moist bacteriocin disinfectant wipes and methods of using the same |
| 04/26/2000 | EP0789716B1 Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for the determination thereof |
| 04/26/2000 | EP0771209A4 Novel peptides |
| 04/26/2000 | EP0680469B1 Aminoacid derivates, medicaments containing these compounds and process for preparing the same |
| 04/26/2000 | EP0656945B1 Stress protein epitopes |
| 04/26/2000 | EP0656013B1 Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus |
| 04/26/2000 | EP0554381B2 Use of protective agents against reactive oxygen species |
| 04/26/2000 | CN1251611A USPA1 and USPA2 antigens of moraxelia catarrhalis |
| 04/26/2000 | CN1251610A Novel mouse CXC chemokine receptor |
| 04/26/2000 | CN1251532A Tissue factor methods and compositions for coagulation and tumor treatment |
| 04/26/2000 | CN1251531A Treatment of inner ear hair cells |
| 04/26/2000 | CN1251530A Use of substaces having oxytocin activity for preparation of medicaments for wound healing |
| 04/26/2000 | CN1251527A Method of treating prostatic disease using delayed and/or sustained release vitamin D formulations |
| 04/26/2000 | CN1251309A Method for preparing medicinal absinthium extracted liquor and electro-moxibustion apparatus using said extracted liquor |
| 04/26/2000 | CN1251296A Use of anticancer material and production method of said anti-cancer material |
| 04/26/2000 | CN1051769C Parathyroid hormone analogues, their production method and medicinal composition containing same |
| 04/26/2000 | CN1051716C Somatotropin prolonged release |
| 04/25/2000 | US6054593 Elastase inhibitor |
| 04/25/2000 | US6054576 Contacting with mixture of anhydrous alkylamine, trialkylamine and polar organic solvent to remove base and phosphate blocking groups, contacting with anhydrous triethylamine.hydrogen fluoride to remove hydroxyl blockers |
| 04/25/2000 | US6054572 Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion |
| 04/25/2000 | US6054569 Nucleotide and amino acid sequences from flavobacterium heparinum; for recombinant production of enyzmes for therapeutic agents |
| 04/25/2000 | US6054567 Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
| 04/25/2000 | US6054565 Nucleic Acids of HIV-2, Diagnostic Test Kit and Method using Nucleic Acid Probes of HIV-2 |
| 04/25/2000 | US6054560 Mitogen activated protein kinase, FRK |
| 04/25/2000 | US6054559 Interleukin-1 receptor antagonist beta (IL-1raβ) |
| 04/25/2000 | US6054558 Amino acid sequence of isolated polypeptide from gene upregulated in endothelial cells in response to shear stress; for treatment and diagnosis of atherosclerosis, hypertension, ischemia/reperfusion, restenosis, and arterial inflammation |
| 04/25/2000 | US6054555 Process for the preparation of immobilized and activity-stabilized complexes of LHRH antagonists |
| 04/25/2000 | US6054490 Use of sesquiterpenes for inhibiting oxidative enzymes |
| 04/25/2000 | US6054489 Method for the enhancement of lymphocyte activity against tumors |
| 04/25/2000 | US6054485 Eye treatments using synthetic thyroid hormone compositions |
| 04/25/2000 | US6054479 Preservative compositions and methods for using the same |
| 04/25/2000 | US6054444 Inhibit n-acetylated alpha-linked acidic dipeptidase (naaladase) enzyme activity |
| 04/25/2000 | US6054440 Antisense inhibition of Jun N-terminal Kinase Kinase-2 expression |
| 04/25/2000 | US6054438 Nucleic acid fragments encoding portions of the core protein of the human mammary epithelial mucin |
| 04/25/2000 | US6054436 Regulated apoptosis |
| 04/25/2000 | US6054432 Means for treating prostate hypertrophy and prostate cancer |
| 04/25/2000 | US6054431 Anti-gram-positive bacterial methods and materials |
| 04/25/2000 | US6054430 Substantially free of species having a molecular weight of over 40 kilodaltons; trifluoroacetyl copolymer-1 treated with hbr. |
| 04/25/2000 | US6054429 Epidural method of producing analgesia |
| 04/25/2000 | US6054427 Polythylene glycol-modified hemoglobin present in a concentration of between 0.1 and 4.0 g/dl; solution having a viscosity at least half that of blood and an oncotic pressure higher than that of plasma. |
| 04/25/2000 | US6054320 Includes a regent which binds to effector of arachidonic acid release in biopsy sample cells and another reagent for detectably labelling binding agent; for early, accurate diagnosis |
| 04/25/2000 | US6054316 Compound 8 to 30 nucleobases in length targeted to 3' or 5'-untranslated regions or coding region of human transcription factor; for diagnosis or prophylaxis of cancer; anticarcinogenic agents |
| 04/25/2000 | US6054313 For diagnosis of persistant hyperinsulinemic hypoglycemia of infancy; for screening drugs and antidiabetic agents; for gene therapy |
| 04/25/2000 | US6054308 Arginase II |
| 04/25/2000 | US6054303 Cyclosporins conjugated at an alanine nitrogen atom to an immunogenic carrier, a ligand, a small organic compound or a label through a linker of alkylene oxide chain or carbonyloxybenzyl group including 1-3 carboxamide groups |
| 04/25/2000 | US6054298 Fringe proteins and pattern formation |
| 04/25/2000 | US6054297 Preparing humanized immunoglobulin from complimentarity and human framework region; obtaining human and mammalian variable domain sequences, detecting, replacing, and adjusting sequences, detect binding, prepare immunoglobulin |
| 04/25/2000 | US6054294 Nucleic acid molecules encoding the neurotrophic factor NNT-1 |
| 04/25/2000 | US6054293 Polypeptide involved in chemotatic response; screening for modulator proteins involved in nerve cell migration |
| 04/25/2000 | US6054292 T-cell receptor protein |
| 04/25/2000 | US6054291 Culturing cells to produce and recover human growth hormone |
| 04/25/2000 | US6054290 Human vesicle binding protein |
| 04/25/2000 | US6054289 Polynucleotides encoding human ADA2 |
| 04/25/2000 | US6054284 Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type I (HIV-1) GP120 and methods of use |
| 04/25/2000 | US6054273 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents |
| 04/25/2000 | US6054265 Screening assays for compounds that inhibit membrane fusion-associated events |
| 04/25/2000 | US6054132 A purified toxin in diagnostic testing for detecting peptic ulceration and gastric malignancy, and as a vaccine for providing immunologic protection against bacterial infection |
| 04/25/2000 | US6054130 Non-splicing variants of gp350/220 |
| 04/25/2000 | US6054125 Purified mite allergen |
| 04/25/2000 | US6054124 A milk or a polypeptide subfraction of milk obtained from the allergen treated host, for preventing or alleviating allergic reactions |
| 04/25/2000 | US6054122 A foamable fibrin matrix comprising fibrinogen or metabolite and an foaming agent which causes fibrinogen to foam during application of fibrinogen to wounded tissue |
| 04/25/2000 | CA2155762C Protein modification method |
| 04/25/2000 | CA2155728C Regulated transcription of targeted genes and other biological events |
| 04/25/2000 | CA2106079C Pegylation of polypeptides |
| 04/25/2000 | CA2098021C Composition used as a therapeutic agent against chronic viral hepatic diseases |
| 04/25/2000 | CA2070095C Microspheres containing biologically-active components, processes for the preparation and uses |
| 04/25/2000 | CA1340977C Scavenger receptor protein and antibody thereto |
| 04/25/2000 | CA1340972C Follistatin and method of purifying same |
| 04/25/2000 | CA1340970C Lipase from gastric mucosa |
| 04/21/2000 | CA2286971A1 A method for the purification of natural phosphorylated peptides, a mixture of phosphopeptides thus obtained and the use thereof |
| 04/20/2000 | WO2000022430A2 Neisseria genomic sequences and methods of their use |
| 04/20/2000 | WO2000022146A1 EXPRESSION AND SECRETION OF icIL-1 RECEPTOR ANTAGONIST TYPE II |
| 04/20/2000 | WO2000022143A2 Protein kinase homologs |
| 04/20/2000 | WO2000022142A2 Cell signaling polypeptides and nucleic acids |
| 04/20/2000 | WO2000022136A2 Recombinant e1a deleted adenoviral vectors |
| 04/20/2000 | WO2000022129A1 Non-endogenous, constitutively activated human g protein-coupled receptors |
| 04/20/2000 | WO2000022127A1 Compositions and methods based upon p35, an isoform of p53 |
| 04/20/2000 | WO2000022126A1 Follistatin-related protein zfsta2 |
| 04/20/2000 | WO2000022123A1 Novel protein war-1 and gene thereof |
| 04/20/2000 | WO2000022120A1 (mbp1) polypeptides capable of interacting with oncogenic mutants of the p53 protein |
| 04/20/2000 | WO2000022119A1 METHOD FOR OBTAINING ACTIVE β-NGF |
| 04/20/2000 | WO2000022118A2 Non-desensitizing ampa-receptors |
| 04/20/2000 | WO2000022117A1 Tumor protein |
| 04/20/2000 | WO2000022116A1 Human mdg1 gene (cbfawb10) |